MedPath

Multiple Sclerosis Intimacy and Sexuality Questionnaire

Completed
Conditions
Multiple Sclerosis
Questionnaires
Sexual Dysfunction
Registration Number
NCT05374031
Lead Sponsor
Bozok University
Brief Summary

Aims: This study aimed to psychometrically evaluate the Turkish version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-15) in women with MS.

Methods: The study included 130 women with MS. The Turkish linguistic validation process of the original English MSISQ-15 was performed according to standardized guidelines. Reliability analysis was evaluated with test-retest analysis and intra-class correlation (ICC). Internal consistency between the items was analyzed using the Cronbach's alpha coefficient. Item analysis results were used to assess the contribution of the items to the scale. In evaluating the validity of the scale, the relationship between the MSISQ and the Female Sexual Function Index (FSFI), the Multiple Sclerosis Quality of Life Questionnaire-54 (MSQOL-54), and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PSIQ-12) was investigated. Psychometric properties were analyzed using internal consistency, test-rest reliability, construct validity, and floor-ceiling effect.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
130
Inclusion Criteria
  • Women over the age of 18 who were literate,
  • who did not have any mental problems preventing cooperation and understanding,
  • who were diagnosed with MS
Exclusion Criteria
  • Having pelvic organ prolapse stage 2 or more;
  • having a history of relapse in the past 30 days;
  • experiencing loss of balance or gait disturbance caused by a condition other than MS;
  • being pregnant; having a history of gynecological, urological and/or neurological surgery;
  • having a history of cesarean or vaginal birth in the past six months;
  • being sexually inactive; and, having urinary tract infections

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Questionnaireday 1

Multiple Sclerosis Quality of Life Questionnaire-54 is used to evaluate the quality of life of patients with MS. Higher scores indicate better quality of life.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Yozgat Bozok University

🇹🇷

Yozgat, Turkey

© Copyright 2025. All Rights Reserved by MedPath